HEALTHCARE REALTY TRUST INC (HR) Fundamental Analysis & Valuation

NYSE:HR • US42226K1051

Current stock price

16.99 USD
+0.18 (+1.07%)
At close:
16.99 USD
0 (0%)
Pre-Market:

This HR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. HR Profitability Analysis

1.1 Basic Checks

  • HR had negative earnings in the past year.
  • In the past year HR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: HR reported negative net income in multiple years.
  • Each year in the past 5 years HR had a positive operating cash flow.
HR Yearly Net Income VS EBIT VS OCF VS FCFHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B -1.5B -2B

1.2 Ratios

  • HR's Return On Assets of -2.70% is on the low side compared to the rest of the industry. HR is outperformed by 75.41% of its industry peers.
  • HR's Return On Equity of -5.39% is on the low side compared to the rest of the industry. HR is outperformed by 67.21% of its industry peers.
  • HR's Return On Invested Capital of 0.85% is on the low side compared to the rest of the industry. HR is outperformed by 82.79% of its industry peers.
  • HR had an Average Return On Invested Capital over the past 3 years of 0.49%. This is below the industry average of 3.11%.
  • The 3 year average ROIC (0.49%) for HR is below the current ROIC(0.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.7%
ROE -5.39%
ROIC 0.85%
ROA(3y)-3.71%
ROA(5y)-1.89%
ROE(3y)-7.38%
ROE(5y)-3.72%
ROIC(3y)0.49%
ROIC(5y)0.83%
HR Yearly ROA, ROE, ROICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • With a Operating Margin value of 8.04%, HR is not doing good in the industry: 76.23% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of HR has declined.
  • The Gross Margin of HR (61.96%) is worse than 63.93% of its industry peers.
  • In the last couple of years the Gross Margin of HR has declined.
Industry RankSector Rank
OM 8.04%
PM (TTM) N/A
GM 61.96%
OM growth 3Y-3.21%
OM growth 5Y-18.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-2.21%
HR Yearly Profit, Operating, Gross MarginsHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HR is destroying value.
  • HR has more shares outstanding than it did 1 year ago.
  • HR has more shares outstanding than it did 5 years ago.
  • HR has a better debt/assets ratio than last year.
HR Yearly Shares OutstandingHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
HR Yearly Total Debt VS Total AssetsHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • HR has an Altman-Z score of 0.23. This is a bad value and indicates that HR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.23, HR perfoms like the industry average, outperforming 40.16% of the companies in the same industry.
  • HR has a debt to FCF ratio of 34.88. This is a negative value and a sign of low solvency as HR would need 34.88 years to pay back of all of its debts.
  • HR has a Debt to FCF ratio of 34.88. This is in the better half of the industry: HR outperforms 72.95% of its industry peers.
  • HR has a Debt/Equity ratio of 0.86. This is a neutral value indicating HR is somewhat dependend on debt financing.
  • HR's Debt to Equity ratio of 0.86 is fine compared to the rest of the industry. HR outperforms 66.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 34.88
Altman-Z 0.23
ROIC/WACC0.13
WACC6.54%
HR Yearly LT Debt VS Equity VS FCFHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B

2.3 Liquidity

  • HR has a Current Ratio of 0.52. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.52, HR is doing worse than 71.31% of the companies in the same industry.
  • A Quick Ratio of 0.52 indicates that HR may have some problems paying its short term obligations.
  • The Quick ratio of HR (0.52) is worse than 71.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
HR Yearly Current Assets VS Current LiabilitesHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 36.61% over the past year.
  • Looking at the last year, HR shows a very negative growth in Revenue. The Revenue has decreased by -25.99% in the last year.
  • Measured over the past years, HR shows a quite strong growth in Revenue. The Revenue has been growing by 9.82% on average per year.
EPS 1Y (TTM)36.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.9%
Revenue 1Y (TTM)-25.99%
Revenue growth 3Y8.18%
Revenue growth 5Y9.82%
Sales Q2Q%-7.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.38% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HR will show a decrease in Revenue. The Revenue will decrease by -0.59% on average per year.
EPS Next Y79.69%
EPS Next 2Y36.33%
EPS Next 3Y25.38%
EPS Next 5YN/A
Revenue Next Year-1.83%
Revenue Next 2Y0.62%
Revenue Next 3Y-1.29%
Revenue Next 5Y-0.59%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HR Yearly Revenue VS EstimatesHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
HR Yearly EPS VS EstimatesHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. HR Valuation Analysis

4.1 Price/Earnings Ratio

  • HR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HR Price Earnings VS Forward Price EarningsHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HR is on the same level as its industry peers.
  • HR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HR is cheaper than 67.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.89
EV/EBITDA 15.01
HR Per share dataHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HR's earnings are expected to grow with 25.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.33%
EPS Next 3Y25.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. HR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.99%, HR is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.54, HR has a dividend in line with its industry peers.
  • HR's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 5.99%

5.2 History

  • The dividend of HR decreases each year by -2.77%.
  • HR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • HR has decreased its dividend recently.
Dividend Growth(5Y)-2.77%
Div Incr Years0
Div Non Decr Years1
HR Yearly Dividends per shareHR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • HR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-155.43%
EPS Next 2Y36.33%
EPS Next 3Y25.38%
HR Yearly Income VS Free CF VS DividendHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B

More info and screens

Find the best dividend stocksShow peers with best dividend

HR Fundamentals: All Metrics, Ratios and Statistics

HEALTHCARE REALTY TRUST INC

NYSE:HR (3/31/2026, 8:04:00 PM)

Premarket: 16.99 0 (0%)

16.99

+0.18 (+1.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners112.31%
Inst Owner Change0.01%
Ins Owners0.67%
Ins Owner Change5.35%
Market Cap5.93B
Revenue(TTM)1.18B
Net Income(TTM)-248.94M
Analysts74
Price Target19.95 (17.42%)
Short Float %4.32%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield 5.99%
Yearly Dividend1.1
Dividend Growth(5Y)-2.77%
DP-155.43%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-24
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)252.87%
Min EPS beat(2)-241.5%
Max EPS beat(2)747.25%
EPS beat(4)1
Avg EPS beat(4)4.85%
Min EPS beat(4)-446.12%
Max EPS beat(4)747.25%
EPS beat(8)1
Avg EPS beat(8)-123.59%
EPS beat(12)2
Avg EPS beat(12)-99.04%
EPS beat(16)4
Avg EPS beat(16)-9.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-1.38%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)2.65%
PT rev (1m)2.92%
PT rev (3m)0.29%
EPS NQ rev (1m)42.86%
EPS NQ rev (3m)42.86%
EPS NY rev (1m)1.41%
EPS NY rev (3m)26.32%
Revenue NQ rev (1m)-1.15%
Revenue NQ rev (3m)-4.24%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.02
P/FCF 51.89
P/OCF 12.97
P/B 1.28
P/tB 1.29
EV/EBITDA 15.01
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.33
FCFY1.93%
OCF(TTM)1.31
OCFY7.71%
SpS3.38
BVpS13.23
TBVpS13.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE -5.39%
ROCE 1.07%
ROIC 0.85%
ROICexc 0.85%
ROICexgc 0.86%
OM 8.04%
PM (TTM) N/A
GM 61.96%
FCFM 9.68%
ROA(3y)-3.71%
ROA(5y)-1.89%
ROE(3y)-7.38%
ROE(5y)-3.72%
ROIC(3y)0.49%
ROIC(5y)0.83%
ROICexc(3y)0.5%
ROICexc(5y)0.84%
ROICexgc(3y)0.5%
ROICexgc(5y)0.85%
ROCE(3y)0.63%
ROCE(5y)1.05%
ROICexgc growth 3Y19.05%
ROICexgc growth 5Y-16.63%
ROICexc growth 3Y19.93%
ROICexc growth 5Y-16.58%
OM growth 3Y-3.21%
OM growth 5Y-18.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-2.21%
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 34.88
Debt/EBITDA 6.05
Cap/Depr 60.8%
Cap/Sales 29.04%
Interest Coverage 0.54
Cash Conversion 69.37%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 0.23
F-Score6
WACC6.54%
ROIC/WACC0.13
Cap/Depr(3y)50.69%
Cap/Depr(5y)87.06%
Cap/Sales(3y)26.04%
Cap/Sales(5y)39.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.9%
EPS Next Y79.69%
EPS Next 2Y36.33%
EPS Next 3Y25.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.99%
Revenue growth 3Y8.18%
Revenue growth 5Y9.82%
Sales Q2Q%-7.57%
Revenue Next Year-1.83%
Revenue Next 2Y0.62%
Revenue Next 3Y-1.29%
Revenue Next 5Y-0.59%
EBIT growth 1Y92.1%
EBIT growth 3Y4.71%
EBIT growth 5Y-10.5%
EBIT Next Year163.92%
EBIT Next 3Y39.92%
EBIT Next 5Y29.2%
FCF growth 1Y-37.34%
FCF growth 3YN/A
FCF growth 5Y17.55%
OCF growth 1Y-8.88%
OCF growth 3Y18.79%
OCF growth 5Y3.33%

HEALTHCARE REALTY TRUST INC / HR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HEALTHCARE REALTY TRUST INC (HR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to HR.


Can you provide the valuation status for HEALTHCARE REALTY TRUST INC?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHCARE REALTY TRUST INC (HR). This can be considered as Overvalued.


What is the profitability of HR stock?

HEALTHCARE REALTY TRUST INC (HR) has a profitability rating of 2 / 10.


Can you provide the financial health for HR stock?

The financial health rating of HEALTHCARE REALTY TRUST INC (HR) is 2 / 10.


Can you provide the dividend sustainability for HR stock?

The dividend rating of HEALTHCARE REALTY TRUST INC (HR) is 4 / 10 and the dividend payout ratio is -155.43%.